Low-density array PCR analysis of reperfusion biopsies: An adjunct to histological analysis

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 4077-4086

  Cravedi, Paolo ^a,b   Maggiore, Umberto ^c   Mannon, Roslyn B ^b,d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF PARMA   (Italy)

^d University of Alabama at Birmingham   (United States)

Author keywords

gene expression; integrin 2; kidney transplant; predictor; reperfusion biopsy

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; BETA2 INTEGRIN; CHEMOKINE; COMPLEMENT COMPONENT C3; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION;

ADULT; AGE FACTORS; ANTIGENS, CD18; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; REPERFUSION; TISSUE DONORS;

EID: 78649500718     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq297     Document Type: Article

References (30)

1. El-Husseini A, Sabry A, Zahran A et al. Can donor implantation renal biopsy predict long-term renal allograft outcome? Am J Nephrol 2007; 27: 144-151
2. Escofet X, Osman H, Griffiths DF et al. The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation. Transplantation 2003; 75: 344-346
3. Randhawa PS, Minervini MI, Lombardero M et al. Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation 2000; 69: 1352-1357
4. Leunissen KM, Bosman FT, Nieman FH et al. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 1989; 48: 590-593
5. Seron D, Carrera M, Grino JM et al. Relationship between donor renal interstitial surface and post-transplant function. Nephrol Dial Transplant 1993; 8: 539-543
6. Lachenbruch PA, Rosenberg AS, Bonvini E et al. Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant 2004; 4: 451-457
7. Mas VR, Archer KJ, Yanek K et al. Gene expression patterns in deceased donor kidneys developing delayed graft function after kidney transplantation. Transplantation 2008; 85: 626-635
8. Mueller TF, Reeve J, Jhangri GS et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008; 8: 78-85
9. Allanach K, Mengel M, Einecke G et al. Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant 2008; 8: 1006-1015
10. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138 (Pubitemid 36818782)
11. Levey AS GT, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828
12. Hoffmann SC, Kampen RL, Amur S et al. Molecular and immuno-histochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002; 74: 916-923
13. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004; 4: 1562-1566
14. Mannon RB, Hoffmann SC, Kampen RL et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005; 5: 2883-2893
15. Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5: 573-581
16. Cohen J. Statistical power analysis in the behavioral sciences. Hills-dale, New Jersey: Laurence Erlbaum Associates, 1988
17. Stata Base Reference Manual Release 11. College Station, TX, USA: Stata Press, 2009; Stata Corp
18. Harrell F. Regression modeling strategies with application to linear models, logistic regression, and survival analysis. New York: Springer-Verlag, 2001
19. Kainz A, Mitterbauer C, Hauser P et al. Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant 2004; 4: 1595-1604
20. Damman J, Schuurs TA, Ploeg RJ et al. Complement and renal transplantation: from donor to recipient. Transplantation 2008; 85: 923-927
21. Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363-1371
22. Csencsits K, Burrell BE, Lu G et al. The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant 2008; 8: 1622-1630
23. Pribila JT, Quale AC, Mueller KL et al. Integrins and T cell-mediated immunity. Annu Rev Immunol 2004; 22: 157-180
24. Liang Y, Liu C, Djeu JY et al. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects. Blood 2008; 111: 954-962
25. Hourmant M, Bedrossian J, Durand D et al. A randomized multicen-ter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62: 1565-1570
26. Hodulik S, Hadi S. Efalizumab: a biological agent for the treatment of psoriasis. Rev Recent Clin Trials 2006; 1: 165-168
27. Vincenti F, MendezR,Pescovitz M et al. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007; 7: 1770-1777
28. Remuzzi G, Cravedi P, Perna A et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343-352
29. Kainz A, Perco P, Mayer B et al. Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation 2007; 83: 1048-1054
30. Chavalitdhamrong D, Gill J, Takemoto S et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation 2008; 85: 1573-1579